EUVIMED · CrossrefZeitschrift
Circulation: Genomic and Precision Medicine
ISSN 2574-8300 · Ovid Technologies (Wolters Kluwer Health)
Neueste Artikel
Cumulative Genetic Burden Defines a Gradient of Risk in MYBPC3 -Related Hypertrophic Cardiomyopathy
Novel Metabolomic Signature as a Biomarker to Detect Subclinical Atherosclerosis in Individuals Traditionally Classified as Low Risk
Genetic-Phenotypic Discordance Reveals Distinct Cardiovascular and Mortality Risk at HDL Cholesterol Extremes
Comparative and Sex-Specific Assessment of Proteomics, Clinical, and Genomic Data on Visceral Adipose Tissue Volume Using Machine Learning in UK Biobank: Advancing Precision Medicine
Investigating the Distinctive Clinical and Genetic Landscape of PPA2 Deficiency
Comparison of Clinical Characteristics Between Patients With HCM With Nontruncating Versus Truncating Variants in MYBPC3
Cross-Ancestry Portability of a Hypertrophic Cardiomyopathy Polygenic Score in a Diverse US Cohort
Family-Based Characterization of COL1A1 -Associated Heritable Aortopathy
Cardiologist-Delivered Genetic Testing in 482 Patients With Cardiomyopathy: The Infrastructure Needed for Mainstream Testing at Scale
Comparing Cardiac Genetic Testing Pathways: Impacts on Access, Informed Choice, and Decisional Satisfaction
Yield of Postmortem Genetic Testing in Sudden Arrhythmic Death Syndrome: A Systematic Review and Meta-Analysis
Detecting and Mitigating Bias for Inclusive and Trustworthy Clinical Research: A Scientific Statement From the American Heart Association
Multiomics for Risk Stratification in Atherosclerotic Cardiovascular Disease
MEK Inhibition Improves Clinical Outcome in Premature Infants With Multisystemic RASA1 Disease
Circulating Cardiovascular Proteomic Associations With Genetics and Disease
Exploring RBFOX2 Haploinsufficiency: A New Genetic Link to Hypoplastic Left Heart Syndrome
Large-Scale Proteomics-Based Risk Score for the Prediction of Incident Cardio-Kidney-Metabolic Disease Risk
Digging Deeper Into Cardiovascular Plasma Proteomics: Opportunities and Limitations of Current Platforms
VEGFA Stop-Gained Variant Deteriorates Cardiac Remodeling in Myocardial Infarction
Lung Single-Cell Transcriptomics Reveal Diverging Pathobiology and Opportunities for Precision Targeting in Scleroderma-Associated Versus Idiopathic Pulmonary Arterial Hypertension
Importance of Clinical, Laboratory, and Genetic Risk Factors for Incident CAD
Molecular Phenogroups in Heart Failure: Large-Scale Proteomics in a Population-Based Cohort
Human Genetics Informing Drug Development in Cardiovascular Disease: Interleukin-6 Signaling as a Case Study
Data Interoperability and Harmonization in Cardiovascular Genomic and Precision Medicine
Effect of Disclosing a Polygenic Risk Score for Coronary Heart Disease on Adverse Cardiovascular Events
Artificial Intelligence to Enhance Precision Medicine in Cardio-Oncology: A Scientific Statement From the American Heart Association
Long Noncoding RNA TRIBAL Links the 8q24.13 Locus to Hepatic Lipid Metabolism and Coronary Artery Disease
Sex-Specific Association Between Genetic Risk of Psychiatric Disorders and Cardiovascular Diseases
Proteome- and Transcriptome-Wide Genetic Analysis Identifies Biological Pathways and Candidate Drug Targets for Preeclampsia
Vascular Ehlers-Danlos Syndrome: A Comprehensive Natural History Study in a Dutch National Cohort of 142 Patients
EUVIMED